It’s more like a committee trapped in an escape room with a hormone department that gets blamed for everything. Aggressive trade? Testosterone. Bad poker face? Testosterone. Bought a motorcycle at 2 a.m.? Ah yes, the usual suspect. But this new meta-analysis delivers a clean situation report: testosterone does not appear to make people broadly more willing to take risks. The hormone may have a tiny, task-specific role here and there, but the grand legend - that testosterone is your internal Vegas concierge - just took a direct hit.

The mission: test a very popular story

Scientists have spent years asking whether testosterone nudges people toward riskier choices. The idea has obvious appeal. Testosterone has a swagger problem in the public imagination. It gets cast as the chemical equivalent of sunglasses indoors.

So Sánchez Rodríguez and colleagues did the sensible thing. They stopped relying on one flashy study at a time and ran a large meta-analysis - basically the scientific version of calling in all available units and checking whether the rumor survives contact with reality. They pooled 52 studies, 94 independent effect sizes, and data from 17,340 people. That is not a tiny pilot study held together by vibes and undergrads.

Their main finding was about as subtle as a locked weapons cabinet: no reliable relationship between testosterone and risk aversion or risk-taking overall. The pooled effect was essentially zero.

Testosterone is not your brain’s daredevil general

That matters because the popular narrative is simple, and simple stories spread like gossip in a small town. Hormone goes up, risky behavior goes up. Clean. Cinematic. Also, according to this paper, mostly unsupported.

The authors looked across different ways researchers measured testosterone and different ways they measured risk. That last part matters more than it sounds. “Risk-taking” is not one thing. Buying volatile stocks, jumping off a roof into a pool, bluffing in poker, and clicking a button in a lab task all get shoved into the same conversational duffel bag. But your brain does not treat them as identical missions.

This meta-analysis found a modest positive association only in lottery-based economic tasks. In other words, when risk looked like choosing between monetary gambles on paper or a screen, testosterone showed a small link. But in other common paradigms - such as the Balloon Analogue Risk Task, Iowa Gambling Task, or self-report questionnaires - the relationship basically vanished.

That is a major tactical note. It suggests we are not looking at one master “risk circuit” with testosterone sitting at the command desk. We are looking at a messy coalition of valuation, reward prediction, impulse control, mood, context, social pressure, and task design. Which is a very brain thing to do. Nothing can ever just be one knob.

Why this matters outside the lab

This paper is useful because people love biological shortcuts. If a hormone explains risky behavior, then the story feels tidy. Too tidy, usually.

In real life, risky decisions depend on context. Are you sleep-deprived? Under social pressure? Gambling with your own money? Showing off? Trying to avoid a loss? Making a split-second choice or a slow one? The brain runs different operations under each condition. Testosterone may affect some narrow pathways in some situations, but this review argues against the idea that it acts like a universal green light for risk.

That has consequences for how we talk about behavior in finance, sports, adolescence, competition, and even crime. It is tempting to say someone had “high testosterone” and therefore made a reckless decision. Convenient. Dramatic. Probably wrong often enough to retire the line.

The enemy here is oversimplification

The paper also pushes back on another common assumption: that any testosterone-risk link should be stronger in men than women. The authors ran a separate meta-analysis on sex differences and found no reliable moderating effect. So that neat little cultural script did not survive inspection either.

This does not mean hormones do nothing. It means broad claims need better evidence. The authors recommend preregistered studies, multiple measures of risk, and direct endocrine assays. Good. The field needs fewer one-off claims and more disciplined operations. If your result only appears in one oddly specific task on alternate Tuesdays, that is not a law of nature. That is a warning label.

This also fits with broader work in decision neuroscience showing that risk is built from several moving parts - reward sensitivity, loss aversion, uncertainty tolerance, learning, and emotional state among them. Reviews in recent years have emphasized that hormones, stress systems, and social context interact in complicated ways rather than marching in a neat hormonal parade [1-5].

Final assessment

The headline is almost rude in its simplicity: testosterone does not generally predict risk aversion. For a field built around a very catchy idea, that is useful news. Null results are not glamorous, but they do the important work of taking bad myths out behind the barn.

So no, testosterone is probably not the tiny chemical warlord ordering your neurons to buy meme stocks and date chaos. Your decision-making system is more complicated, less cinematic, and frankly more annoying than that. The strategic assets include hormones, yes - but also context, cognition, emotion, and whatever bizarre rules your brain invents when money, status, and uncertainty show up at the same table.

That is less sexy than the myth. It is also more likely to be true.

References

1. Sánchez Rodríguez I, Bailo L, Panizza F, Ricciardi E, Bossi F. No relationship between testosterone and risk aversion: A meta-analytic review. Neurosci Biobehav Rev. 2026; doi:10.1016/j.neubiorev.2026.106575

2. Vila-Balló A, Mas-Herrero E, Ripollés P, et al. Unraveling the role of testosterone in economic decision-making: a systematic review. Neurosci Biobehav Rev. 2023;146:105040. doi:10.1016/j.neubiorev.2023.105040

3. Soutschek A, Schubert T. Hormonal influences on human risk-taking and decision-making: a review of recent evidence. Curr Opin Behav Sci. 2022;46:101170. doi:10.1016/j.cobeha.2022.101170

4. FeldmanHall O, Glimcher P, Baker AL, Phelps EA. Emotion and decision-making under uncertainty: recent neural and computational advances. Annu Rev Psychol. 2024;75:219-245. doi:10.1146/annurev-psych-020423-030123

5. van den Bos R, Homberg J, de Visser L. A critical review of sex differences in decision-making tasks involving risk and ambiguity. Neurosci Biobehav Rev. 2021;127:741-760. doi:10.1016/j.neubiorev.2021.05.012

Disclaimer: The image accompanying this article is for illustrative purposes only and does not depict actual experimental results, data, or biological mechanisms.